BACITRACIN ZINC; POLYMYXIN B SULFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bacitracin zinc; polymyxin b sulfate and what is the scope of freedom to operate?
Bacitracin zinc; polymyxin b sulfate
is the generic ingredient in four branded drugs marketed by Glaxosmithkline, Bausch And Lomb, Padagis Us, Sciegen Pharms Inc, Pharmafair, Monarch Pharms, and Naska, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.Seven suppliers are listed for this compound.
Summary for BACITRACIN ZINC; POLYMYXIN B SULFATE
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 7 |
| Clinical Trials: | 1 |
| DailyMed Link: | BACITRACIN ZINC; POLYMYXIN B SULFATE at DailyMed |
Recent Clinical Trials for BACITRACIN ZINC; POLYMYXIN B SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Glaxo Wellcome | N/A |
See all BACITRACIN ZINC; POLYMYXIN B SULFATE clinical trials
Pharmacology for BACITRACIN ZINC; POLYMYXIN B SULFATE
| Drug Class | Polymyxin-class Antibacterial |
| Physiological Effect | Decreased Cell Wall Synthesis & Repair |
Anatomical Therapeutic Chemical (ATC) Classes for BACITRACIN ZINC; POLYMYXIN B SULFATE
US Patents and Regulatory Information for BACITRACIN ZINC; POLYMYXIN B SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 064046-001 | Jan 26, 1995 | AT | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Monarch Pharms | POLYSPORIN | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 061229-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Naska | BACITRACIN ZINC-POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;TOPICAL | 062849-001 | Nov 13, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Us | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 065022-001 | Feb 27, 2002 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Glaxosmithkline | POLYSPORIN | bacitracin zinc; polymyxin b sulfate | AEROSOL;TOPICAL | 050167-002 | Mar 1, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
